Compositions and methods for therapy and diagnosis of cancer

Details for Australian Patent Application No. 2006322213 (hide)

Owner Ganymed Pharmaceuticals AG Johannes Gutenberg-Universitat Mainz vertreten durch den Prasidenten

Inventors Tureci, Ozlem; Sahin, Ugur; Koslowski, Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006322213

PCT Pub. Number WO2007/065690

Priority EP 05 026 874.7 08.12.05 EP

Filing date 7 December 2006

Wipo publication date 14 June 2007

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/065690 Priority application(s): WO2007/065690

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006322227-Optimization of software transactional memory operations

2006322209-End plug for a roll of material, roll of material and retention mechanism in a dispenser